ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,717,000 | +23.8% | 188,931 | -41.7% | 0.00% | 0.0% |
| Q4 2017 | $1,387,000 | +117.7% | 324,026 | -28.3% | 0.00% | +100.0% |
| Q3 2017 | $637,000 | -38.5% | 451,861 | -34.6% | 0.00% | -50.0% |
| Q2 2017 | $1,036,000 | +55.8% | 690,630 | +166.9% | 0.00% | +100.0% |
| Q1 2017 | $665,000 | -35.1% | 258,752 | -35.6% | 0.00% | -50.0% |
| Q4 2016 | $1,025,000 | -25.6% | 401,900 | -9.9% | 0.00% | 0.0% |
| Q3 2016 | $1,378,000 | -28.4% | 446,065 | -25.6% | 0.00% | -50.0% |
| Q2 2016 | $1,925,000 | -30.8% | 599,810 | -33.2% | 0.00% | -42.9% |
| Q1 2016 | $2,783,000 | -21.9% | 897,867 | +1.1% | 0.01% | 0.0% |
| Q4 2015 | $3,563,000 | -9.1% | 888,442 | +3.8% | 0.01% | -12.5% |
| Q3 2015 | $3,921,000 | -3.7% | 856,141 | +9.1% | 0.01% | 0.0% |
| Q2 2015 | $4,071,000 | -19.7% | 784,407 | -3.1% | 0.01% | -11.1% |
| Q1 2015 | $5,068,000 | -9.6% | 809,632 | -9.2% | 0.01% | -25.0% |
| Q4 2014 | $5,607,000 | +16.4% | 891,342 | +12.5% | 0.01% | 0.0% |
| Q3 2014 | $4,816,000 | +158.8% | 792,093 | +180.5% | 0.01% | +140.0% |
| Q2 2014 | $1,861,000 | -69.3% | 282,388 | +10.8% | 0.01% | -72.2% |
| Q1 2014 | $6,069,000 | +1790.7% | 254,929 | +958.3% | 0.02% | +1700.0% |
| Q3 2013 | $321,000 | +79.3% | 24,088 | +77.2% | 0.00% | 0.0% |
| Q2 2013 | $179,000 | – | 13,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |